Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

AARTI PHARMALABS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 15.1210.707.811.22-3.76

What is the latest EV/Core EBITDA ratio of AARTI PHARMALABS ?

The latest EV/Core EBITDA ratio of AARTI PHARMALABS is 15.12 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202515.12
Mar202410.70
Mar20237.81
Mar20221.22
Mar2021-3.76

How is EV/Core EBITDA of AARTI PHARMALABS Trending?

Years EV/Core EBITDA % Change
Mar2025 15.12
41.31
Mar2024 10.7
37.00
Mar2023 7.81
540.16
Mar2022 1.22
Positive
Mar2021 -3.76 -

Other Financial Ratios of AARTI PHARMALABS


Compare EV/Core EBITDA ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹6,249.2 Cr 6.1% 1.1% -15.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

6.1%

1.1%

-15.5%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses